Find Diacerein manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

USP

0

JP

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 13739-02-1, Diacerhein, Diacetylrhein, Artrodar, Fisiodar, 1,8-diacetoxy-3-carboxyanthraquinone
Molecular Formula
C19H12O8
Molecular Weight
368.3  g/mol
InChI Key
TYNLGDBUJLVSMA-UHFFFAOYSA-N
FDA UNII
4HU6J11EL5

Diacerein
Diacerein is a prodrug which is metabolized to rhein. It is currently approved in France for the treatment of osteoarthritis although the use of diacerein is restricted due to the side effects including severe diarrhea. Diacerein is under investigation for the treatment of Insulin Resistance, Diabetes Mellitus (Type 2), and Diabetes-Related Complications.
1 2D Structure

Diacerein

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4,5-diacetyloxy-9,10-dioxoanthracene-2-carboxylic acid
2.1.2 InChI
InChI=1S/C19H12O8/c1-8(20)26-13-5-3-4-11-15(13)18(23)16-12(17(11)22)6-10(19(24)25)7-14(16)27-9(2)21/h3-7H,1-2H3,(H,24,25)
2.1.3 InChI Key
TYNLGDBUJLVSMA-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(=O)OC1=CC=CC2=C1C(=O)C3=C(C2=O)C=C(C=C3OC(=O)C)C(=O)O
2.2 Other Identifiers
2.2.1 UNII
4HU6J11EL5
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1,8-diacetoxy-3-carboxyanthraquinone

2. 2-anthracenecarboxylic Acid, 4,5-bis(acetyloxy)-9,10-dihydro-9,10-dioxo-

3. 4,5-bis(acetyloxy)-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic Acid

4. 4,5-diacetoxyanthraquinone-2-carboxylic Acid

5. 9,10-dihydro-4,5-dihydroxy-9,10-dioxo-2-anthroic Acid, Diacetate

6. Ac-201

7. Ac-203

8. Artrodar

9. Diacerhein

10. Diacetyl-rhein

11. Diacetylrhein

12. Diora

13. Fisiodar

14. M-01ax21

15. M01ax21

16. Rhein Diacetate

17. Sf-277

18. Sf277

19. Verboril

20. Zondar

2.3.2 Depositor-Supplied Synonyms

1. 13739-02-1

2. Diacerhein

3. Diacetylrhein

4. Artrodar

5. Fisiodar

6. 1,8-diacetoxy-3-carboxyanthraquinone

7. Diacerin

8. Sf-277

9. Verboril

10. Zondar

11. Diora

12. 4,5-diacetyloxy-9,10-dioxoanthracene-2-carboxylic Acid

13. M01ax21

14. Ac-201

15. 2-anthracenecarboxylic Acid, 4,5-bis(acetyloxy)-9,10-dihydro-9,10-dioxo-

16. 4,5-bis(acetyloxy)-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic Acid

17. 4,5-diacetoxyanthraquinone-2-carboxylic Acid

18. M-01ax21

19. Diacerhein; Diacetylrhein

20. Mfcd00468030

21. Nsc-758147

22. Mls000028577

23. 4hu6j11el5

24. 4,5-diacetoxy-9,10-dioxo-9,10-dihydroanthracene-2-carboxylic Acid

25. 9,10-dihydro-4,5-dihydroxy-9,10-dioxo-2-anthroic Acid, Diacetate

26. 4,5-diacetylrhein

27. Ncgc00018274-04

28. Smr000058958

29. 4,5-bis(acetyloxy)-9,10-dioxo-9,10-dihydroanthracene-2-carboxylic Acid

30. Dsstox_cid_25636

31. Dsstox_rid_81017

32. Diacerein [inn]

33. Dsstox_gsid_45636

34. Diacereine [french]

35. Diacereinum [latin]

36. Diacereina [spanish]

37. 4,5-diacetoxy-9,10-diketo-anthracene-2-carboxylic Acid

38. 4,5-diacetyloxy-9,10-dioxo-2-anthracenecarboxylic Acid

39. Diacereina

40. Diacereine

41. Diacereinum

42. Rhein Diacetate

43. Rhein, Diacetate

44. Cas-13739-02-1

45. Sr-01000003156

46. Einecs 237-310-2

47. Brn 2184909

48. Unii-4hu6j11el5

49. Gesamtmatrix

50. Art 50

51. 1,8-diacetoxyanthraquinone-3-carboxylic Acid

52. Diacerein- Bio-x

53. Zondar (tn)

54. Spectrum_001876

55. Specplus_000643

56. 4,5-diacetoxy-9,10-dihydro-9,10-dioxo-2-anthrylcarbonsaeure

57. 9,10-dihydro-4,5-diacetoxy-9,10-2-anthracenecarboxylic Acid

58. Diacerein [mi]

59. Diacerein (usan/inn)

60. Diacerein [usan:inn]

61. Diacerein [usan]

62. 9,10-dihydro-4,5-dihydroxy-9,10-dioxo-2-anthroic Acid Diacetate

63. Spectrum2_000823

64. Spectrum3_000937

65. Spectrum4_001036

66. Spectrum5_001819

67. Diacerein Impurity Mixture

68. Diacerein [mart.]

69. Diacerein [who-dd]

70. Schembl25784

71. Kbiogr_001591

72. Kbioss_002400

73. Rhein Diacetate [mi]

74. 3-10-00-04790 (beilstein Handbook Reference)

75. Cid_26248

76. Chembl41286

77. Divk1c_006739

78. Spectrum1502010

79. Spbio_000745

80. 4,5-diacetoxy-9,10-dioxo-anthracene-2-carboxylic Acid

81. Diacerein [ep Monograph]

82. Diacerein, >=95% (hplc)

83. Dtxsid4045636

84. Bdbm32018

85. Chebi:94708

86. Gtpl10800

87. Kbio1_001683

88. Kbio2_002395

89. Kbio2_004963

90. Kbio2_007531

91. Kbio3_001974

92. Hms3652d06

93. Hms3714b20

94. Pharmakon1600-01502010

95. Bcp10834

96. Hy-n0283

97. Who 5371

98. Zinc3812842

99. Tox21_110856

100. Bbl011075

101. Ccg-40287

102. Nsc758147

103. S4267

104. Stk802271

105. 2-anthroic Acid, 9,10-dihydro-4,5-dihydroxy-9,10-dioxo-, Diacetate

106. Akos005622705

107. Tox21_110856_1

108. Db11994

109. Ks-5088

110. Kw-4800

111. Nsc 758147

112. Ncgc00018274-01

113. Ncgc00018274-02

114. Ncgc00018274-03

115. Ncgc00018274-05

116. Ncgc00022114-03

117. Am807992

118. Bd164367

119. Sbi-0052833.p002

120. B1726

121. D4061

122. Ft-0603096

123. Sw199355-2

124. D07270

125. Ab00053327_14

126. 739d021

127. A807252

128. Q413178

129. Sr-01000003156-2

130. Sr-01000003156-3

131. Sr-01000003156-4

132. W-108237

133. Diacerein, European Pharmacopoeia (ep) Reference Standard

134. 4,5-diacetoxy-9,10-dihydro-9,10-dioxoanthracene-2-carboxylic Acid

135. 4,5-diacetyloxy-9,10-bis(oxidanylidene)anthracene-2-carboxylic Acid

136. 4,5-bis(acetoxy)-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic Acid

137. 112118-18-0

2.4 Create Date
2005-06-29
3 Chemical and Physical Properties
Molecular Weight 368.3 g/mol
Molecular Formula C19H12O8
XLogP31.9
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count8
Rotatable Bond Count5
Exact Mass368.05321734 g/mol
Monoisotopic Mass368.05321734 g/mol
Topological Polar Surface Area124 Ų
Heavy Atom Count27
Formal Charge0
Complexity683
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

For the treatment of osteoarthritis affecting the hip or knee.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Decreases inflammation and cartilage destruction and also corrects altered osteoblast acitivity.


5.2 MeSH Pharmacological Classification

Anti-Inflammatory Agents

Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)


5.3 ATC Code

M - Musculo-skeletal system

M01 - Antiinflammatory and antirheumatic products

M01A - Antiinflammatory and antirheumatic products, non-steroids

M01AX - Other antiinflammatory and antirheumatic agents, non-steroids

M01AX21 - Diacerein


5.4 Absorption, Distribution and Excretion

Absorption

Bioavailability of 50-60%. Entirely converted to the active metabolite rhein [DB13174] before reaching systemic circulation.


Route of Elimination

37% excreted in urine and 53% in feces as estimated in rats.


Volume of Distribution

15-60L.


Clearance

Total CL is 1.5L/h and renal CL is 0.1L/h.


5.5 Metabolism/Metabolites

Entirely converted to rhien [DB13174] through double deacetylation before reaching systemic circulation. Rhein [DB13174] is further metabolized to rhein glucuronide and rhein sulfate.


5.6 Biological Half-Life

4-10h.


5.7 Mechanism of Action

Diacerein's active metabolite rhein [DB13174] reduces cartilage destruction by decreasing expression of matrix metalloproteinase (MMP)-1 and -3 as well as upregulating tissue inhibitor of matrix metalloproteinases which serve to reduce the activity of several MMPs. The anti-inflammatory action of rhein reduces the level of interleukin-1beta activity which plays a large role in reduction of extracellular matrix production, MMP activity, and continued inflammation. Rhein reduces abnormal osteoblast synthetic activity through an unknown mechanism.


Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 13739-02-1 / Diacerein API manufacturers, exporters & distributors?

Diacerein manufacturers, exporters & distributors 1

43

PharmaCompass offers a list of Diacerein API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Diacerein manufacturer or Diacerein supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Diacerein manufacturer or Diacerein supplier.

PharmaCompass also assists you with knowing the Diacerein API Price utilized in the formulation of products. Diacerein API Price is not always fixed or binding as the Diacerein Price is obtained through a variety of data sources. The Diacerein Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Diacerein

Synonyms

13739-02-1, Diacerhein, Diacetylrhein, Artrodar, Fisiodar, 1,8-diacetoxy-3-carboxyanthraquinone

Cas Number

13739-02-1

Unique Ingredient Identifier (UNII)

4HU6J11EL5

About Diacerein

Diacerein is a prodrug which is metabolized to rhein. It is currently approved in France for the treatment of osteoarthritis although the use of diacerein is restricted due to the side effects including severe diarrhea. Diacerein is under investigation for the treatment of Insulin Resistance, Diabetes Mellitus (Type 2), and Diabetes-Related Complications.

Diacerein Manufacturers

A Diacerein manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diacerein, including repackagers and relabelers. The FDA regulates Diacerein manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diacerein API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Diacerein manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Diacerein Suppliers

A Diacerein supplier is an individual or a company that provides Diacerein active pharmaceutical ingredient (API) or Diacerein finished formulations upon request. The Diacerein suppliers may include Diacerein API manufacturers, exporters, distributors and traders.

click here to find a list of Diacerein suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Diacerein USDMF

A Diacerein DMF (Drug Master File) is a document detailing the whole manufacturing process of Diacerein active pharmaceutical ingredient (API) in detail. Different forms of Diacerein DMFs exist exist since differing nations have different regulations, such as Diacerein USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Diacerein DMF submitted to regulatory agencies in the US is known as a USDMF. Diacerein USDMF includes data on Diacerein's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Diacerein USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Diacerein suppliers with USDMF on PharmaCompass.

Diacerein KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Diacerein Drug Master File in Korea (Diacerein KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Diacerein. The MFDS reviews the Diacerein KDMF as part of the drug registration process and uses the information provided in the Diacerein KDMF to evaluate the safety and efficacy of the drug.

After submitting a Diacerein KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Diacerein API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Diacerein suppliers with KDMF on PharmaCompass.

Diacerein CEP

A Diacerein CEP of the European Pharmacopoeia monograph is often referred to as a Diacerein Certificate of Suitability (COS). The purpose of a Diacerein CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Diacerein EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Diacerein to their clients by showing that a Diacerein CEP has been issued for it. The manufacturer submits a Diacerein CEP (COS) as part of the market authorization procedure, and it takes on the role of a Diacerein CEP holder for the record. Additionally, the data presented in the Diacerein CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Diacerein DMF.

A Diacerein CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Diacerein CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Diacerein suppliers with CEP (COS) on PharmaCompass.

Diacerein WC

A Diacerein written confirmation (Diacerein WC) is an official document issued by a regulatory agency to a Diacerein manufacturer, verifying that the manufacturing facility of a Diacerein active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Diacerein APIs or Diacerein finished pharmaceutical products to another nation, regulatory agencies frequently require a Diacerein WC (written confirmation) as part of the regulatory process.

click here to find a list of Diacerein suppliers with Written Confirmation (WC) on PharmaCompass.

Diacerein NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Diacerein as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Diacerein API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Diacerein as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Diacerein and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Diacerein NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Diacerein suppliers with NDC on PharmaCompass.

Diacerein GMP

Diacerein Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Diacerein GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diacerein GMP manufacturer or Diacerein GMP API supplier for your needs.

Diacerein CoA

A Diacerein CoA (Certificate of Analysis) is a formal document that attests to Diacerein's compliance with Diacerein specifications and serves as a tool for batch-level quality control.

Diacerein CoA mostly includes findings from lab analyses of a specific batch. For each Diacerein CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Diacerein may be tested according to a variety of international standards, such as European Pharmacopoeia (Diacerein EP), Diacerein JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diacerein USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty